Christina Lopes is the CEO and co-founder of the One Health Company, whose flagship

product, FidoCure, uses AI and genomic sequencing to provide personalized treatments for pet

dogs with cancer and accelerates the development of lifesaving cancer drugs for humans.

Under Christina’s leadership FidoCure has expanded into over 1,350 veterinary clinics around

the world and treated more than 5,000 pet dogs with cancer. In partnership with Stanford

University’s AI Health leadership, Christina has built the world’s largest and most

comprehensive canine cancer dataset, which consists of over 2 billion data points collected from

patients in real world environments. Christina has co-authored peer reviewed research in

leading scientific journals including Nature Precision Oncology that validate FidoCure’s

personalized cancer treatment efficacy by up to 3X survival times, identify novel indications for

existing cancer drugs, and accelerate the development of new cancer drugs via new insights

into genomics. Christina’s work has been featured in the Washington Post, WIRED, STAT, The

Times, and many other media outlets around the world. Previously, Christina was Managing

Director at Cerberus Capital ($50B AUM) and helped create new financial asset classes in

emerging markets. Christina is a graduate of Columbia University, was recognized at the World

Economic Forum at Davos as a Young Global Leader, and an Inc. Magazine top 100 emale

founder. She is a Y-Combinator founder and is backed by leading investment firms such as

Andreessen Horowitz and Lerer Hippeau. She served as Advisory Board Director to

International Planned Parenthood for the Western Hemisphere, which provides 30M health

services annually and has previously participated in the United Nations Commission for the

Status of Women.